Pdb104 - Impact of Dapagliflozin on Reducing Economic Burden of Diabetes in Egypt

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.809
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pdb40 - Impact of Dapagliflozin on Reducing Economic Burden of Type 2 Diabetes &Enhancement Patient’s Outcomes at Countries With High Incidence of Diabetes Egypt Case

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Estimated Lifetime Economic Burden of Type 1 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

PDB40 Economic Burden of Type 2 Diabetes Mellitus in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Economic Burden of Diabetes Mellitus in the WHO African Region

BMC International Health and Human Rights
EnvironmentalPublic HealthOccupational Health
2009English

Economic Burden of Moderate Chronic Kidney Disease in Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Economic Burden of Hypoglycemia for Type II Diabetes Mellitus Patients in Malaysia

PLoS ONE
Multidisciplinary
2019English

Reducing the Burden of Mortality in Older People With Diabetes: A Review of Current Research

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2020English

Patient Recommendations for Reducing Long-Lasting Economic Burden After Breast Cancer

Cancer
Cancer ResearchOncology
2019English

Economic Evaluation of Dapagliflozin Versus Metformin in Chinese Patients Whose Diabetes Is Inadequately Controlled With Diet and Exercise

Cost Effectiveness and Resource Allocation
Health Policy
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy